Pharmacology
 |
|
10 april 2019 08:04:05 |
| Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer (Pharmacogenomics Journal) |
|
Tweet |
| 134 viewsCategory: Genomics, Pharmacology |
 Impact of CYP2D6 and ADRB1 polymorphisms on heart rate of post-PCI patients treated with metoprolol (Pharmacogenomics)Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
